Results 111 to 120 of about 3,285,062 (216)

Lipophilicity study of ursodeoxycholic acid

open access: yesCurrent Issues in Pharmacy and Medical Sciences, 2012
In this work, the researchers determined the chromatographic parameter of the lipophilicity (RMW) of ursodeoxycholic acid under various chromatographic conditions, and using the RP-TLC and RP-HPTLC methods. This chromatographic analysis was performed on
Małgorzata Dołowy
doaj   +1 more source

Translating gut microbiome research into therapies for type 1 diabetes

open access: yesExperimental Physiology, EarlyView.
Abstract Type 1 diabetes (T1D) is characterised by the loss of functional pancreatic β‐cells, for which lifelong insulin therapy remains the standard of care. Given that the gut microbiome can influence host health and that shifts in gut microbial profiles have been observed in T1D, growing interest has emerged in the role of the gut microbiome in T1D,
Shanti P. Kok   +2 more
wiley   +1 more source

Genotype–Phenotype Correlations of Monoallelic PFIC Variants in Pediatric Liver Disease: A Multicenter Retrospective Cohort Study

open access: yesAmerican Journal of Medical Genetics Part A, Volume 200, Issue 12, Page 2692-2707, December 2026.
ABSTRACT Progressive familial intrahepatic cholestasis (PFIC) is classically caused by biallelic pathogenic variants, yet monoallelic variants of uncertain significance (VUS) in PFIC‐associated genes are increasingly identified in children with cholestasis, creating diagnostic uncertainty.
Brett J. Hoskins   +9 more
wiley   +1 more source

Associations Between Liver Biomarkers and Clinical Outcomes in Patients With Primary Sclerosing Cholangitis: A Retrospective Real‐World Study

open access: yesLiver International Communications, Volume 7, Issue 4, December 2026.
ABSTRACT Background and Aims This retrospective observational study assessed whether liver biomarker levels and their temporal changes can predict clinical outcomes in patients with primary sclerosing cholangitis (PSC). Approach and Results Adults with any cholangitis diagnosis in the TriNetX Dataworks‐USA network during the study period (2011–2021 ...
Jun Xu   +10 more
wiley   +1 more source

Temporal Analysis of Gestation at Birth in Pregnancies Complicated by Intrahepatic Cholestasis of Pregnancy

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 6, December 2026.
ABSTRACT Intrahepatic cholestasis of pregnancy (ICP) is associated with maternal morbidity and adverse perinatal outcomes and has historically been managed with planned early birth. This retrospective study examined temporal trends in gestational age at birth among 943 ICP pregnancies at an Australian tertiary hospital between 2014 and 2024, spanning ...
Cynthia Wong   +4 more
wiley   +1 more source

Ursodeoxycholic acid for chronic liver diseases

open access: yes, 1988
Different bile acids have different effects on liver cells, depending on the degree of hydroxylation of the bile acid and the orientation of hydroxy groups. In decreasing order of hydrophobicity, and therefore hepatotoxicity, the bile acids may be ranked
E. Bertolini   +6 more
core   +1 more source

ABCB4 Deficiency Presenting as a Pruritus‐Free Continuous Spectrum From Childhood Cholestasis to Adult Cirrhosis: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 11, November 2026.
ABSTRACT Progressive familial intrahepatic cholestasis type 3 (PFIC3) is caused by biallelic mutations in the ABCB4 gene and typically presents in childhood. However, the full phenotypic spectrum—particularly adult‐onset and pruritus‐free forms—remains under‐recognized.
Rongxia Ma   +3 more
wiley   +1 more source

Combined rifampicin and ursodeoxycholic acid treatment does not amplify rifampicin effects on hepatic detoxification and transport systems in humans

open access: yes, 2012
Rifampicin (RIFA) and ursodeoxycholic acid (UDCA) were found to stimulate different but complementary hepatobiliary detoxification pathways in gallstone ...
Silbert, Dagmar   +15 more
core   +1 more source

Ascites Presenting as a Peritonitis‐Like Manifestation and Liver Injury due to Trabectedin Monotherapy in a Patient With Myxoid Liposarcoma

open access: yesCancer Reports, Volume 9, Issue 11, November 2026.
ABSTRACT Background Trabectedin is a synthetic, marine‐derived antitumor agent that exerts cytotoxic effects by binding to the minor groove of DNA. While trabectedin has demonstrated efficacy in advanced soft tissue sarcomas, hepatotoxicity and other adverse events remain concerns.
Tatsuyuki Kawahara   +11 more
wiley   +1 more source

Quantitative Systems Toxicology Model Predicts Obeticholic Acid‐Associated Liver Injury in Metabolic Dysfunction‐Associated Steatotic Liver Disease

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 5, Page 1358-1367, November 2026.
Obeticholic acid (OCA), a synthetic analog of chenodeoxycholic acid, was approved in 2016 for the treatment of primary biliary cholangitis. Early clinical trials revealed elevated liver biomarkers in healthy subjects receiving supratherapeutic OCA doses (100–250 mg).
Abigail K. Mayo   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy